I am a
Home I AM A Search Login

Papers of the Week


Papers: 10 Dec 2022 - 16 Dec 2022


Pharmacology/Drug Development


2022


J Pain Res


15

CBD Retailers in NC Promote CBD Online to Treat Pain Violating FDA Rules About Medical Claims and Offer Low-CBD/High-Price Products.

Authors

Amann L, Kruse E, Lazard AJ, Reboussin BA, Wagoner KG, Romero-Sandoval AE
J Pain Res. 2022; 15:3847-3858.
PMID: 36514481.

Abstract

Cannabidiol (CBD) products are available nearly nationwide in the US and can coexist with medical or recreational programs. North Carolina (NC) is an example of a state with a program dedicated to integrating hemp cultivation and medicinal CBD exclusively, containing a multitude of retailers selling it as a primary product. The Food and Drug Administration (FDA) mandates that non-FDA approved CBD products cannot be marketed using medical or health-related claims and has sent warning letters to retailers violating these terms. We aim to characterize the online content of the NC CBD market by analyzing retailers' websites to determine whether hemp/CBD shops comply with FDA regulations in terms of medical claims and analyze the claimed CBD content and price of products offered online.